Tci Gene Inc. (6879) Stock Statistics & Valuation Metrics
Total Valuation
Tci Gene Inc. has a market cap or net worth of TWD 916.79M. The enterprise value is ―.
- Market Cap
- TWD 916.79M
- Enterprise Value
- ―
Share Statistics
Tci Gene Inc. has 26,458,520 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 26,458,520
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Tci Gene Inc.’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is 2.28%.
- Return on Equity (ROE)
- 0.05
- Return on Assets (ROA)
- 0.04
- Return on Invested Capital (ROIC)
- 2.28%
- Return on Capital Employed (ROCE)
- 0.02
- Revenue Per Employee
- 5.47M
- Profits Per Employee
- 811.32K
- Employee Count
- 50
- Asset Turnover
- 0.27
- Inventory Turnover
- 6.45
Valuation Ratios
The current PE Ratio of Tci Gene Inc. is 17.97. Tci Gene Inc.’s PEG ratio is 0.38.
- PE Ratio
- 17.97
- PS Ratio
- 3.63
- PB Ratio
- 1.00
- Price to FCF
- 8.48
- Price to Operating Cash Flow
- 8.49
- PEG Ratio
- 0.38
Income Statement
In the last 12 months, Tci Gene Inc. had revenue of 273.61M and earned 40.57M in profits. Earnings per share was 1.53.
- Revenue
- 273.61M
- Gross Profit
- 152.59M
- Operating Income
- 20.93M
- Pretax Income
- 38.97M
- Net Income
- 40.57M
- EBITDA
- 32.91M
- Earnings Per Share (EPS)
- 1.53
Cash Flow
In the last 12 months, operating cash flow was 107.92M and capital expenditures -247,000, giving a free cash flow of 107.67M billion.
- Operating Cash Flow
- 107.92M
- Free Cash Flow
- 107.67M
- Free Cash Flow per Share
- 4.05
Dividends & Yields
Tci Gene Inc. pays an annual dividend of ―, resulting in a dividend yield of 5.77%
- Dividend Per Share
- ―
- Dividend Yield
- 5.77%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 11.38%
- Earnings Yield
- 5.33%
Stock Price Statistics
- Beta
- 0.33
- 52-Week Price Change
- -12.06%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- 29.61
- Average Volume (3m)
- 2,148
Financial Position
Tci Gene Inc. as a current ratio of 9.27, with Debt / Equity ratio of 0.80%
- Current Ratio
- 9.27
- Quick Ratio
- 9.08
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -7.40
- Interest Coverage Ratio
- 14.97
Taxes
In the past 12 months, Tci Gene Inc. has paid -108.00K in taxes.
- Income Tax
- -108.00K
- Effective Tax Rate
- -0.00
Enterprise Valuation
Tci Gene Inc. EV to EBITDA ratio is 20.44, with an EV/FCF ratio of 7.55.
- EV to Sales
- 3.23
- EV to EBITDA
- 20.44
- EV to Free Cash Flow
- 7.55
- EV to Operating Cash Flow
- 7.53
Balance Sheet
Tci Gene Inc. has TWD 859.36M in cash and marketable securities with TWD 3.88M in debt, giving a net cash position of TWD 855.48M billion.
- Cash & Marketable Securities
- TWD 859.36M
- Total Debt
- TWD 3.88M
- Net Cash
- TWD 855.48M
- Net Cash Per Share
- TWD 32.33
- Tangible Book Value Per Share
- TWD 35.15
Margins
Gross margin is 57.67%, with operating margin of 11.62%, and net profit margin of 20.14%.
- Gross Margin
- 57.67%
- Operating Margin
- 11.62%
- Pretax Margin
- 20.56%
- Net Profit Margin
- 20.14%
- EBITDA Margin
- 15.82%
- EBIT Margin
- 11.62%
Analyst Forecast
The average price target for Tci Gene Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -22.59%
- EPS Growth Forecast
- 41.39%
